118 related articles for article (PubMed ID: 27768539)
1. Therapeutic Effects of CT-guided Radiofrequency Ablation with Concurrent Platinum-Doublet Chemotherapy in a Rabbit VX2 Lung Tumor Model.
Ueki A; Okuma T; Hamamoto S; Miki Y
Radiology; 2017 May; 283(2):391-398. PubMed ID: 27768539
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy involving radiofrequency ablation and targeted chemotherapy with bevacizumab plus paclitaxel and cisplatin in a rabbit VX2 lung tumor model.
Ueki A; Okuma T; Hamamoto S; Kageyama K; Murai K; Miki Y
BMC Res Notes; 2018 Apr; 11(1):251. PubMed ID: 29690935
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Radiofrequency Ablation with Intratumoral Cisplatin Administration in a Rabbit VX2 Lung Tumor Model.
Murai K; Hamamoto S; Okuma T; Kageyama K; Yamamoto A; Ogawa S; Nota T; Sohgawa E; Jogo A; Miki Y
Cardiovasc Intervent Radiol; 2021 Mar; 44(3):475-481. PubMed ID: 33165680
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits.
Hamamoto S; Okuma T; Yamamoto A; Kageyama K; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
Radiology; 2013 May; 267(2):405-13. PubMed ID: 23440322
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness.
Lee JM; Jin GY; Li CA; Chung GH; Lee SY; Han YM; Chung MJ; Kim CS
Invest Radiol; 2003 Feb; 38(2):129-39. PubMed ID: 12544076
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Shukuya T; Takahashi T; Harada H; Akamatsu H; Sakaguchi C; Imai H; Ono A; Nakamura Y; Tsuya A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
Anticancer Res; 2012 Feb; 32(2):675-80. PubMed ID: 22287762
[TBL] [Abstract][Full Text] [Related]
9. Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer.
Horiuchi M; Oguri T; Kagawa Y; Sone K; Fukuda S; Uemura T; Takakuwa O; Maeno K; Fukumitsu K; Kanemitsu Y; Tajiri T; Ohkubo H; Takemura M; Ito Y; Niimi A
Anticancer Res; 2022 Feb; 42(2):1073-1079. PubMed ID: 35093909
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
[TBL] [Abstract][Full Text] [Related]
11. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
12. Combination radiofrequency ablation and local injection of the immunostimulant bacillus Calmette-Guérin induces antitumor immunity in the lung and at a distant VX2 tumor in a rabbit model.
Hamamoto S; Okuma T; Yamamoto A; Kageyama K; Ueki A; Matsuoka T; Miki Y
J Vasc Interv Radiol; 2015 Feb; 26(2):271-8. PubMed ID: 25443457
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
Naito Y; Kubota K; Nihei K; Fujii T; Yoh K; Niho S; Goto K; Ohmatsu H; Saijo N; Nishiwaki Y
J Thorac Oncol; 2008 Jun; 3(6):617-22. PubMed ID: 18520801
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors.
Kageyama K; Yamamoto A; Okuma T; Hamamoto S; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1383-92. PubMed ID: 23737021
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in Japan.
Kenmotsu H; Ohde Y; Shukuya T; Eida H; Akamatsu H; Ono A; Nakamura Y; Tsuya A; Kaira K; Naito T; Murakami H; Takahashi T; Maniwa T; Isaka M; Endo M; Kondo H; Yamamoto N
Respir Investig; 2012 Dec; 50(4):157-61. PubMed ID: 23199980
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged survival through combined treatment with radiofrequency ablation/ethanol instillation compared with radiofrequency ablation alone in the VX2 rabbit liver tumour model].
Frieser M; Schaber S; Strobel D; Bernatik T; Wehr H; Peters A; Hahn EG; Haensler J
Ultraschall Med; 2007 Apr; 28(2):176-80. PubMed ID: 17447217
[TBL] [Abstract][Full Text] [Related]
20. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
